Psychedelic Therapist Training
Psychedelic Therapist Training covers the use of psychedelic substances in therapy, with topics including history, current research, safety, harm reduction, ethics, and session facilitation. It is presented as training for mental health and medical professionals, as well as others interested in psychedelic therapy.
Course Overview
Psychedelic Therapist Training is a course category focused on the use of psychedelics in therapeutic settings. The source text describes psychedelic therapy as a specialized form of psychiatric therapy using substances such as LSD, psilocybin, and MDMA to support emotional and psychological growth. The listed courses cover a range of topics, including the history and current research on psychedelic therapy, safety and harm reduction, ethical considerations, and practical training in administering and facilitating psychedelic sessions. The page says these courses are intended for professionals in mental health and medical fields, as well as individuals interested in learning more about psychedelic therapy. The training is described as preparing participants to understand how psychedelics are used in therapy and to develop the knowledge and skills needed to incorporate them safely and effectively into practice. Specific course structure varies across the listed programs.
Who is this for?
Professionals in mental health and medical fields, and individuals interested in psychedelic therapy
Course Details
- PriceFree
- Lifecycle statusNo New Dates
- SkillsHarm ReductionIntegrationFacilitationPsychotherapyKetamine-Assisted TherapyPsilocybin TherapyMDMA-Assisted TherapyMicrodosingEthicsTrauma-Informed Carepsychedelic therapysafety and harm reductionethical considerationssession facilitation
- Categories
You will be redirected to the provider's website
Related Courses
View all coursesCertificate in Psychedelic-Assisted Therapies & Research | CIISCIIS LogoCIIS Logo
A 12-month certificate in psychedelic-assisted therapies and research offered by CIIS. The program includes hybrid or online study and covers clinical competencies, research, cultural context, and ethical practice.
FDA On MDMA-Assisted Psychotherapy
This page discusses the FDA's rejection of MDMA-assisted psychotherapy and summarizes the rationale given for further research. It also reviews MDMA's history, reported therapeutic uses, and MAPS' response to the decision.
Automated status check: No valid upcoming cohort date found on the source page (checked 2026-04-12).
MAPS International MDMA-assisted Therapy Training Program
A collaboration between MAPS and the Clinical Psychedelic Lab at Monash University, this training program prepares mental healthcare professionals to support MDMA-assisted psychotherapy for PTSD. It combines online learning with a week-long in-person residential intensive and is limited to 65 trainees.
Automated status check: No valid upcoming cohort date found on the source page (checked 2026-04-12).